Axsome Therapeutics, Inc. — All Filings
616 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-25-205260 | Sep 16, 2025 | Sep 12, 2025 |
| 144 | — | 0001958244-25-004332 | Sep 15, 2025 | — |
| 144 | — | 0001958244-25-004329 | Sep 12, 2025 | — |
| 4 | 4 | 0000950170-25-113874 | Sep 9, 2025 | Sep 8, 2025 |
| 4 | 4 | 0000950170-25-113311 | Sep 5, 2025 | — |
| 144 | — | 0001921094-25-001106 | Sep 5, 2025 | — |
| 144 | — | 0001921094-25-001057 | Sep 2, 2025 | — |
| 4 | 4 | 0001231615-25-000008 | Sep 2, 2025 | — |
| 144 | — | 0001921094-25-001050 | Aug 29, 2025 | — |
| 4 | 4 | 0001231615-25-000006 | Aug 29, 2025 | Aug 27, 2025 |
| 144 | — | 0001921094-25-001043 | Aug 28, 2025 | — |
| 144 | — | 0001921094-25-001039 | Aug 27, 2025 | — |
| 4 | 4 | 0001231615-25-000004 | Aug 26, 2025 | Aug 22, 2025 |
| 144 | — | 0001921094-25-001033 | Aug 26, 2025 | — |
| 144 | — | 0001921094-25-001014 | Aug 22, 2025 | — |
| 8-K | 8-K | 0001579428-25-000007 | Aug 20, 2025 | Aug 19, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-021702 | Aug 14, 2025 | — |
| S-8 | S-8 | 0000950170-25-105192 | Aug 7, 2025 | — |
| 8-K | 8-K | 0000950170-25-101624 | Aug 4, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-102148 | Aug 4, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-089158 | Jun 23, 2025 | Jun 20, 2025 |
| 144 | — | 0001921094-25-000710 | Jun 23, 2025 | — |
| 144 | — | 0001921094-25-000702 | Jun 20, 2025 | — |
| 144 | — | 0001921094-25-000693 | Jun 18, 2025 | — |
| 4 | 4 | 0000950170-25-088105 | Jun 18, 2025 | Jun 16, 2025 |
| 144 | — | 0001921094-25-000689 | Jun 17, 2025 | — |
| 144 | — | 0001921094-25-000670 | Jun 16, 2025 | — |
| 8-K | 8-K | 0000950170-25-084098 | Jun 10, 2025 | — |
| 4 | 4 | 0000950170-25-084556 | Jun 10, 2025 | Jun 9, 2025 |
| 4 | 4 | 0000950170-25-084554 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | 4 | 0000950170-25-084559 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | 4 | 0000950170-25-084555 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | 4 | 0000950170-25-084560 | Jun 10, 2025 | Jun 6, 2025 |
| 8-K | 8-K | 0000950170-25-083441 | Jun 9, 2025 | — |
| 144 | — | 0001921094-25-000627 | Jun 9, 2025 | — |
| 8-K | 8-K | 0000950170-25-083793 | Jun 9, 2025 | Jun 6, 2025 |
| 4 | 4 | 0000950170-25-079229 | May 29, 2025 | May 27, 2025 |
| 144 | — | 0001921094-25-000563 | May 28, 2025 | — |
| 144 | — | 0001921094-25-000564 | May 28, 2025 | — |
| 4 | 4 | 0000950170-25-078552 | May 28, 2025 | May 27, 2025 |
| 8-K | 8-K | 0000950170-25-077374 | May 27, 2025 | — |
| 144 | — | 0001921094-25-000561 | May 27, 2025 | — |
| 144 | — | 0001921094-25-000562 | May 27, 2025 | — |
| 4 | 4 | 0000950170-25-075539 | May 20, 2025 | — |
| 144 | — | 0001921094-25-000534 | May 20, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-072022 | May 15, 2025 | — |
| 8-K | 8-K | 0000950170-25-069785 | May 13, 2025 | May 8, 2025 |
| 10-Q | 10-Q | 0000950170-25-063634 | May 5, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-063158 | May 5, 2025 | — |
| ARS | ARS | 0000950170-25-058788 | Apr 25, 2025 | Dec 31, 2024 |